1-methoxy-4-((2-methylbut-3-en-2-yl)oxy)benzene | 34125-71-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-methoxy-4-((2-methylbut-3-en-2-yl)oxy)benzene
• 英文别名: 4-(1,1-dimethyl-2-propenyloxy)anisole；1-methoxy-4-(2-methylbut-3-en-2-yloxy)benzene
• CAS: 34125-71-8
• 化学式: C₁₂H₁₆O₂
• 分子量: 192.258
• InChiKey: KIVFPLGMSWCNPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-methoxy-4-((2-methylbut-3-en-2-yl)oxy)benzene 在 hexane chloroform 作用下， 以 邻二氯苯 为溶剂， 反应 2.0h， 以the aimed product was obtained as red oily substance (2-step, yield: 61%)的产率得到6-methoxy-2,2-dimethyl-2H-chromene
  参考文献：
  名称：

  Benzopyran Compound

  摘要：

  本发明涉及式（I）的苯并吡喃化合物，其中X为NR6，Y为键，SO或SO2，Z为C1-4烷基或苯基，W为氢原子，羟基，C1-6烷氧基，卤素原子，C1-4烷基或C1-6烷基磺酰氨基，R1和R2分别为C1-3烷基，R3为氢原子，羟基或甲氧基，m为0至4的整数，n为0至4的整数，V为单键，CR7R8，NR9，O，S，SO或SO2，R4为氢原子或C1-6烷基，R5为氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，C6-14芳基或C2-9杂芳基。这些化合物可用作抗心律失常剂。

  公开号：

  US20070299130A1
• 作为产物：
  描述：

  1-(1,1-dimethyl-2-propynyloxy)-4-methoxy benzene 在 palladium on barium sulfate 喹啉 、 氢气 作用下， 以 乙醇 为溶剂， 生成 1-methoxy-4-((2-methylbut-3-en-2-yl)oxy)benzene
  参考文献：
  名称：

  Hlubucek,J. et al., Australian Journal of Chemistry, 1971, vol. 24, p. 2355 - 2363

  摘要：

  DOI：

文献信息

• Redox-Active Triazolium-Derived Ligands in Nucleophilic Fe-Catalysis - Reactivity Profile and Development of a Regioselective<i>O</i>-Allylation
  作者：Johannes E. M. N. Klein、Michael S. Holzwarth、Stephan Hohloch、Biprajit Sarkar、Bernd Plietker

  DOI：10.1002/ejoc.201300902

  日期：2013.10

  Triazolium-derived N-heterocyclic carbene (aNHC) ligands, which are readily accessible by deprotonation of the corresponding triazolium salts, proved to be versatile ligands in diverse allylic substitution reactions. The corresponding triazolium salts are formed from azides and alkynes through the application of 1,3-dipolar cycloaddition and N-alkylation reactions. The unique property of these ligands

  三唑鎓衍生的 N-杂环卡宾 (aNHC) 配体通过相应三唑鎓盐的去质子化很容易获得，被证明是各种烯丙基取代反应中的通用配体。相应的三唑鎓盐是由叠氮化物和炔烃通过 1,3-偶极环加成和 N-烷基化反应形成的。这些配体的独特性质是在其释放形式时是两性离子的，并作为强氧化还原活性 σ-供体配体。凭借这些特性，这些配体能够开发出前所未有的 Fe 催化的烯丙基碳酸酯区域选择性芳氧基化。
• [EN] TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS<br/>[FR] COMPOSE DE BENZOPYRANNE TRICYCLIQUE EN TANT QU'AGENTS ANTI-ARRYTHMIQUES
  申请人：NISSAN CHEMICAL IND LTD

  公开号：WO2005090357A1

  公开（公告）日：2005-09-29

  This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R1 and R2 are independently of each other hydrogen atom, C1-6alkyl group or C6-14aryl group, R3 is hydrogen atom or C1-6alkylcarbonyloxy group, or together with R4 forms a bond, R4 is hydrogen atom, or together with R3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R5 is hydrogen atom or C1-6alkyl group, R6 is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, amino group, C1-6alkylamino group, di-C1-6alkylamino group, C6-14arylamino group, C2-9heteroarylamino group, C6-14aryl group, C2-9heteroaryl group or C2-9heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.

  本发明涉及公式（I）或（II）的苯并吡喁衍生物，或其药学上可接受的盐，其中R1和R2分别是氢原子、C1-6烷基或C6-14芳基，R3是氢原子或C1-6烷基羰氧基，或与R4一起形成键，R4是氢原子，或与R3一起形成键，m是0到4的整数，n是0到4的整数，V是单键，CR7R8，NR9，O，S，SO或SO2，R5是氢原子或C1-6烷基，R6是氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环烷基，A是与苯环融合的5、6或7成员环，作为环的组成原子，氧原子、氮原子或硫原子可以单独或组合地包含在其中，环中的不饱和键数为1、2或3，包括与苯环融合的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
• Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents
  申请人：Ohrai Kazuhiko

  公开号：US20080004262A1

  公开（公告）日：2008-01-03

  This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R 1 and R 2 are independently of each other hydrogen atom, C 1-6 alkyl group or C 6-14 aryl group, R 3 is hydrogen atom or C 1-6 alkylcarbonyloxy group, or together with R 4 forms a bond, R 4 is hydrogen atom, or together with R 3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR 7 R 8 , NR 9 , O, S, SO or SO 2 , R 5 is hydrogen atom or C 1-6 alkyl group, R 6 is hydrogen atom, C 1-6 alkyl group, C 3-8 cycloalkyl group, C 3-8 cycloalkenyl group, amino group, C 1-6 alkylamino group, di-C 1-6 alkylamino group, C 6-14 arylamino group, C 2-9 heteroarylamino group, C 6-14 aryl group, C 2-9 heteroaryl group or C 2-9 heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.

  本发明涉及式（I）或（II）的苯并吡喃衍生物，或其药学上可接受的盐，其中R1和R2独立地为氢原子，C1-6烷基或C6-14芳基；R3为氢原子或C1-6烷基羰氧基，或与R4一起形成键；R4为氢原子，或与R3一起形成键；m为0至4的整数，n为0至4的整数，V为单键，CR7R8，NR9，O，S，SO或SO2；R5为氢原子或C1-6烷基，R6为氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环烷基；A为与苯环融合的5、6或7元环，作为环的组成原子，其中单独或组合存在1至3个氧原子、氮原子或硫原子，环中不饱和键的数量为1、2或3，包括与苯环融合的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
• [EN] BENZOPYRAN COMPOUND USEFUL FOR THE TREATMENT OF ARRHYTMIA<br/>[FR] COMPOSÉ DE BENZOPYRANE
  申请人：NISSAN CHEMICAL IND LTD

  公开号：WO2005080368A3

  公开（公告）日：2005-11-10
• BENZOPYRAN COMPOUNDS USEFUL FOR THE TREATMENT OF ARRHYTMIA
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP1718629A2

  公开（公告）日：2006-11-08